Ketoconazole as an adrenal steroidogenesis inhibitor: effectiveness and risks in the treatment of Cushing's disease

J Clin Endocrinol Metab. 2014 May;99(5):1586-8. doi: 10.1210/jc.2014-1622.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • 14-alpha Demethylase Inhibitors / therapeutic use*
  • Female
  • Humans
  • Ketoconazole / therapeutic use*
  • Male
  • Pituitary ACTH Hypersecretion / drug therapy*

Substances

  • 14-alpha Demethylase Inhibitors
  • Ketoconazole